Invesco’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.24M Buy
470,333
+384,566
+448% +$2.65M ﹤0.01% 2387
2025
Q1
$247K Buy
85,767
+55,791
+186% +$161K ﹤0.01% 3413
2024
Q4
$141K Sell
29,976
-686
-2% -$3.22K ﹤0.01% 3564
2024
Q3
$109K Sell
30,662
-381
-1% -$1.36K ﹤0.01% 3590
2024
Q2
$192K Sell
31,043
-465,636
-94% -$2.89M ﹤0.01% 3617
2024
Q1
$4.69M Buy
496,679
+20,473
+4% +$193K ﹤0.01% 2276
2023
Q4
$3.21M Buy
+476,206
New +$3.21M ﹤0.01% 2438
2023
Q2
Sell
-12,469
Closed -$35.5K 3867
2023
Q1
$35.5K Sell
12,469
-509
-4% -$1.45K ﹤0.01% 3757
2022
Q4
$94.5K Buy
12,978
+1,737
+15% +$12.6K ﹤0.01% 3814
2022
Q3
$90K Buy
11,241
+141
+1% +$1.13K ﹤0.01% 3827
2022
Q2
$55K Sell
11,100
-212,360
-95% -$1.05M ﹤0.01% 3930
2022
Q1
$5.28M Buy
223,460
+115,993
+108% +$2.74M ﹤0.01% 2339
2021
Q4
$1.9M Sell
107,467
-488,590
-82% -$8.64M ﹤0.01% 2797
2021
Q3
$16.8M Buy
+596,057
New +$16.8M ﹤0.01% 1673